• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Peroxisome proliferator-activated receptors (PPARs) in dermatology: Challenge and promise.皮肤病学中的过氧化物酶体增殖物激活受体(PPARs):挑战与前景。
Dermatoendocrinol. 2011 Jul;3(3):130-5. doi: 10.4161/derm.3.3.15025. Epub 2011 Jul 1.
2
Peroxisome proliferator-activated receptors (PPARs) and the human skin: importance of PPARs in skin physiology and dermatologic diseases.过氧化物酶体增殖物激活受体(PPARs)与人体皮肤:PPARs在皮肤生理学和皮肤病中的重要性
Am J Clin Dermatol. 2008;9(1):15-31. doi: 10.2165/00128071-200809010-00002.
3
Peroxisome proliferator-activated receptors (PPARs) and PPAR agonists: the 'future' in dermatology therapeutics?过氧化物酶体增殖物激活受体(PPARs)与PPAR激动剂:皮肤病治疗的“未来”?
Arch Dermatol Res. 2015 Nov;307(9):767-80. doi: 10.1007/s00403-015-1571-1. Epub 2015 May 19.
4
Peroxisome proliferator-activated receptors in cutaneous biology.皮肤生物学中的过氧化物酶体增殖物激活受体
Br J Dermatol. 2003 Aug;149(2):229-36. doi: 10.1046/j.1365-2133.2003.05532.x.
5
The role of PPARγ-mediated signalling in skin biology and pathology: new targets and opportunities for clinical dermatology.PPARγ介导的信号传导在皮肤生物学和病理学中的作用:临床皮肤科的新靶点与机遇
Exp Dermatol. 2015 Apr;24(4):245-51. doi: 10.1111/exd.12647.
6
Peroxisome proliferators and peroxisome proliferator activated receptors (PPARs) as regulators of lipid metabolism.过氧化物酶体增殖物与过氧化物酶体增殖物激活受体(PPARs)作为脂质代谢的调节因子。
Biochimie. 1997 Feb-Mar;79(2-3):81-94. doi: 10.1016/s0300-9084(97)81496-4.
7
Biology and therapeutic applications of peroxisome proliferator- activated receptors.过氧化物酶体增殖物激活受体的生物学和治疗应用。
Curr Top Med Chem. 2012;12(6):548-84. doi: 10.2174/156802612799436669.
8
Peroxisome proliferator-activated receptors and their relevance to dermatology.过氧化物酶体增殖物激活受体及其与皮肤病学的相关性。
Acta Derm Venereol. 2005;85(3):194-202. doi: 10.1080/00015550510030104.
9
Peroxisome proliferator-activated receptors (PPARs) in skin health, repair and disease.过氧化物酶体增殖物激活受体(PPARs)与皮肤健康、修复及疾病
Biochim Biophys Acta. 2007 Aug;1771(8):991-8. doi: 10.1016/j.bbalip.2007.02.004. Epub 2007 Feb 24.
10
Multifaceted roles of peroxisome proliferator-activated receptors (PPARs) at the cellular and whole organism levels.过氧化物酶体增殖物激活受体 (PPARs) 在细胞和整体水平上的多方面作用。
Swiss Med Wkly. 2010 Sep 15;140:w13071. doi: 10.4414/smw.2010.13071. eCollection 2010.

引用本文的文献

1
Mode and Mechanism of Action of Omega-3 and Omega-6 Unsaturated Fatty Acids in Chronic Diseases.ω-3和ω-6不饱和脂肪酸在慢性病中的作用方式及作用机制
Nutrients. 2025 Apr 30;17(9):1540. doi: 10.3390/nu17091540.
2
The Role of Linoleic Acid in Skin and Hair Health: A Review.亚油酸在皮肤和头发健康中的作用:综述
Int J Mol Sci. 2024 Dec 30;26(1):246. doi: 10.3390/ijms26010246.
3
PPARs in Clinical Experimental Medicine after 35 Years of Worldwide Scientific Investigations and Medical Experiments.经过 35 年的全球科学研究和医学实验,PPARs 在临床实验医学中的应用。
Biomolecules. 2024 Jul 1;14(7):786. doi: 10.3390/biom14070786.
4
New Insights into the Role of PPARγ in Skin Physiopathology.PPARγ 在皮肤生理病理中的作用新见解。
Biomolecules. 2024 Jun 19;14(6):728. doi: 10.3390/biom14060728.
5
PPARs (Peroxisome Proliferator-activated Receptors) and Their Agonists in Alzheimer's Disease.过氧化物酶体增殖物激活受体及其激动剂在阿尔茨海默病中的作用。
Med Chem. 2024;20(8):781-798. doi: 10.2174/0115734064295063240422100615.
6
Fatty Acids Profile and the Relevance of Membranes as the Target of Nutrition-Based Strategies in Atopic Dermatitis: A Narrative Review.脂肪酸谱与细胞膜作为特应性皮炎营养策略靶点的相关性:叙述性综述。
Nutrients. 2023 Sep 4;15(17):3857. doi: 10.3390/nu15173857.
7
A network pharmacology and molecular docking investigation on the mechanisms of Shanyaotianhua decoction (STT) as a therapy for psoriasis.基于网络药理学和分子对接技术研究山瑶天花汤治疗银屑病的作用机制。
Medicine (Baltimore). 2023 Aug 25;102(34):e34859. doi: 10.1097/MD.0000000000034859.
8
The Activation of PPARγ by (2Z,4E,6E)-2-methoxyocta-2,4,6-trienoic Acid Counteracts the Epithelial-Mesenchymal Transition Process in Skin Carcinogenesis.(2Z,4E,6E)-2-甲氧基-辛-2,4,6-三烯酸激活 PPARγ 可拮抗皮肤癌变过程中的上皮-间充质转化。
Cells. 2023 Mar 24;12(7):1007. doi: 10.3390/cells12071007.
9
Considerations of the Genetic Background of Obesity among Patients with Psoriasis.考虑银屑病患者肥胖的遗传背景。
Genes (Basel). 2023 Feb 26;14(3):594. doi: 10.3390/genes14030594.
10
Keratin 17 Is Required for Lipid Metabolism in Keratinocytes and Benefits Epidermal Permeability Barrier Homeostasis.角蛋白17是角质形成细胞脂质代谢所必需的,并有助于维持表皮渗透屏障的稳态。
Front Cell Dev Biol. 2022 Jan 12;9:779257. doi: 10.3389/fcell.2021.779257. eCollection 2021.

本文引用的文献

1
Natural peroxisome proliferator-activated receptor-alpha agonist cream demonstrates similar therapeutic response to topical steroids in atopic dermatitis.天然过氧化物酶体增殖物激活受体-α激动剂乳膏在特应性皮炎中的治疗反应与局部皮质类固醇相似。
J Dermatolog Treat. 2011 Dec;22(6):359-65. doi: 10.3109/09546634.2010.499932. Epub 2010 Oct 22.
2
Zileuton, a new efficient and safe systemic anti-acne drug.齐留通,一种新型高效且安全的全身性抗痤疮药物。
Dermatoendocrinol. 2009 May;1(3):188-92. doi: 10.4161/derm.1.3.8368.
3
Activation of PPARbeta/delta causes a psoriasis-like skin disease in vivo.过表达 PPARβ/δ导致体内出现银屑病样皮肤疾病。
PLoS One. 2010 Mar 16;5(3):e9701. doi: 10.1371/journal.pone.0009701.
4
Rosiglitazone alleviates the persistent fibrotic phenotype of lesional skin scleroderma fibroblasts.罗格列酮缓解皮损性硬皮病成纤维细胞的持续纤维化表型。
Rheumatology (Oxford). 2010 Feb;49(2):259-63. doi: 10.1093/rheumatology/kep371. Epub 2009 Dec 9.
5
Ligand activation of peroxisome proliferator-activated receptor-beta/delta and inhibition of cyclooxygenase-2 enhances inhibition of skin tumorigenesis.配体激活过氧化物酶体增殖物激活受体-β/δ 和抑制环氧化酶-2 增强抑制皮肤肿瘤发生。
Toxicol Sci. 2010 Jan;113(1):27-36. doi: 10.1093/toxsci/kfp212. Epub 2009 Sep 11.
6
Loss of peroxisome proliferator-activated receptor gamma in mouse fibroblasts results in increased susceptibility to bleomycin-induced skin fibrosis.小鼠成纤维细胞中过氧化物酶体增殖物激活受体γ的缺失导致对博来霉素诱导的皮肤纤维化易感性增加。
Arthritis Rheum. 2009 Sep;60(9):2822-9. doi: 10.1002/art.24761.
7
Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells.黑色素瘤细胞中维生素D受体(VDR)信号与过氧化物酶体增殖物激活受体(PPAR)信号之间的相互作用。
Anticancer Res. 2009 Sep;29(9):3647-58.
8
Cyclooxygenase 2 (COX2) and Peroxisome Proliferator-Activated Receptor Gamma (PPARG) Are Stage-Dependent Prognostic Markers of Malignant Melanoma.环氧化酶 2(COX2)和过氧化物酶体增殖物激活受体γ(PPARG)是恶性黑色素瘤的阶段依赖性预后标志物。
PPAR Res. 2009;2009:848645. doi: 10.1155/2010/848645. Epub 2009 Jul 20.
9
In vitro and in vivo anti-melanoma effects of ciglitazone.噻唑烷二酮对黑色素瘤的体内外抗瘤作用
J Invest Dermatol. 2009 May;129(5):1208-18. doi: 10.1038/jid.2008.346. Epub 2009 Jan 29.
10
Rosiglitazone abrogates bleomycin-induced scleroderma and blocks profibrotic responses through peroxisome proliferator-activated receptor-gamma.罗格列酮可消除博来霉素诱导的硬皮病,并通过过氧化物酶体增殖物激活受体γ阻断促纤维化反应。
Am J Pathol. 2009 Feb;174(2):519-33. doi: 10.2353/ajpath.2009.080574. Epub 2009 Jan 15.

皮肤病学中的过氧化物酶体增殖物激活受体(PPARs):挑战与前景。

Peroxisome proliferator-activated receptors (PPARs) in dermatology: Challenge and promise.

作者信息

Sertznig Pit, Reichrath Jörg

机构信息

Department of Dermatology; RWTH Aachen University Hospital; Aachen.

出版信息

Dermatoendocrinol. 2011 Jul;3(3):130-5. doi: 10.4161/derm.3.3.15025. Epub 2011 Jul 1.

DOI:10.4161/derm.3.3.15025
PMID:22110772
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3219163/
Abstract

Since their discovery it has become clear that peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors involved in the genetic regulation of the lipid metabolism and energy homoeostasis. Subsequently, accumulating evidence suggests a role of PPARs in genomic pathways including the regulation of cell growth, apoptosis and differentiation. These findings indicate that PPARs and PPAR agonists play an important role in inflammatory responses and tumor promotion. Because of their diverse biologic activities on keratinocytes and other skin cells, PPARs represent a major research target for the understanding and treatment of many skin pathologies, such as hyperproliferative and inflammatory diseases. Overmore recent clinical trials identified PPARs as promising drug targets for the prevention and treatment of various diseases in the field of dermatology. The present review summarizes the current knowledge of PPAR functions in various skin disorders particularly those involving inflammation and epidermal hyperproliferation (i.e., psoriasis, atopic dermatitis, acne, scleroderma, skin malignancies).

摘要

自过氧化物酶体增殖物激活受体(PPARs)被发现以来,已明确其为配体激活的转录因子,参与脂质代谢和能量稳态的基因调控。随后,越来越多的证据表明PPARs在包括细胞生长、凋亡和分化调控在内的基因组途径中发挥作用。这些发现表明PPARs和PPAR激动剂在炎症反应和肿瘤促进中起重要作用。由于PPARs对角质形成细胞和其他皮肤细胞具有多种生物学活性,它们是理解和治疗许多皮肤疾病(如增殖性和炎症性疾病)的主要研究靶点。此外,最近的临床试验确定PPARs是皮肤病领域预防和治疗各种疾病的有前景的药物靶点。本综述总结了PPARs在各种皮肤疾病,特别是那些涉及炎症和表皮过度增殖(如银屑病、特应性皮炎、痤疮、硬皮病、皮肤恶性肿瘤)中的功能的当前知识。